Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 901–1,000 of 1,000
Adult growth hormone deficiency: academic extravagance or real clinical entity for the internist?
Scanelli, G., Catapano, L., Traverso, B., & Aimoni, C. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2008.3.4
García-Doncel, L. G., Triviño‐Ibáñez, E. M., García, I. S., & Nieto, G. B. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.09.002
Insulin receptor and IGF-I receptor Bioactivity in Health and Disease
Varewijck, A. J. (2013) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Hypophysenvorderlappen-Insuffizienz als Folge von Schädel-Hirn-Trauma und Subarachnoidalblutung
Lehmann, S. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17171
Management of Adult Growth Hormone Deficiency
Hizuka, N. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch38
Wang, X., Yu, H., Sun, L. P., Hs, J., Dong, G., Fu, J., & Liang, L. (2013) · Cited by 1
Hypopituitarism: Recognition, Workup, and Management
Brue, T. C. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch36
Club bibliográfico Tratamiento con rhGH en pacientes hiposomatotrópicos previamente acromegálicos
Mercado, M. (2009) · Revista de Endocrinología y Nutrición
Macedo, J. F., Gomes, L. M. O., & Melo, K. (2013) · JBRA · doi:10.5935/1518-0557.20130061
Treatment of pituitary dwarfism in children and teenagers in the Stavropol territory
Klimov, L., Atanesyan, R. A., Углова, Т. А., Вдовина, Т. М., Kuryaninovna, V. A., Stoyan, M., Dolbnya, S. V., Alaverdyan, L. S., Аракелян, Р. И., Славицкая, Е. С., et al. (2016) · Problems of Endocrinology · doi:10.14341/probl201662110-15
Glucagon Testing in Adult Growth Hormone Deficiency – Current Status and Future Perspectives
Yuen, K. C. J. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2011.07.02.104
Hormone for "Anti-Aging" and Bodybuilding New Developments in the Illegal Provision of Growth
Olshansky, S. J., & Perls, T. T. (2008)
Yuen, K. C. J., Rhoads, S. A., Cook, D. M., Gurel, B. M. H., CHU, K., Salvatori, C. R., Spiller, K. L., & Gordon, M. B. (2013)
1. Obesity Secondary to Endocrinological Disorders
Yanase, T., Nomiyama, T., & Tanabe, M. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.690
Wagler, V. D., Patel, S. J., & LeMar, H. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00035-8
Traumatic Brain Injury and Growth Hormone Deficiency
Richmond, E. J., & Rogol, A. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-28038-7_14
Endocrine Consequences: Diagnostic Workout and Treatment
Giavoli, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-22297-4_7
Seike, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55790-6_12 · Cited by 1
Use of l-Arginine with Growth Hormone-Releasing Hormone (GHRH) and the Endocrine Response
Brigante, G., & Rochira, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-26009-9_13 · Cited by 1
Indicaciones e interpretación diagnóstica de las pruebas funcionales hipofisarias
Fernández, C., Troyano, M. J. R., Trifu, D. S., & Montes, P. G. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.06.023
Disorders of Growth and Development: Diagnosis and Treatment
Bhansali, A., Aggarwal, A., Parthan, G., & Gogate, Y. (2016) · Springer eBooks · doi:10.1007/978-81-322-2815-8_2
Spontaneous Remission of Acromegaly Following Subclinical Pituitary Apoplexy
İpekçi, S. H., & Çakır, M. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Posttreatment Management of Cushing’s Disease
Prete, A., & Salvatori, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00009-7 · Cited by 1
Przypadek choroby wieńcowej u pacjenta z niedoczynnością przysadki
Linka, J., Junik, R., Wróbel, W., & Nowak, K. W. (2013) · Via Medica Journals
Enhancing the limit of detection of biomarkers in serum using a SPRi nano-aptasensor
Vance, S. A. (2015) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Analysis of Factors Related to Hypopituitarism in Patients with Nonsellar Intracranial Tumor
Lu, S., Gu, J., Luo, X., Zhang, J., & Wang, S. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.03.116
García-Doncel, L. G., Triviño‐Ibáñez, E. M., García, I. S., & Nieto, G. B. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.12.025
Hiroual, S., Doubli, S. B., & Matrane, A. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.07.112
Borson‐Chazot, F., Pascal-Vigneron, V., Salenave, S., Hacques, E., & Villette, B. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.07.101
Craniopharyngioma and Posttreatment Pituitary Dysfunction in Brain Tumors
Felicetti, F. C., Prencipe, N., Brignardello, E., & Arvat, E. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_5
Physiopathology, Diagnosis, and Treatment of GH Deficiency
Tanrıverdi, F., & Keleştimur, F. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_2-1
Klefter, O. N., & Feldt‐Rasmussen, U. (2008) · 10th European Congress of Endocrinology
Doknić, M. (2018) · Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma · doi:10.5937/medgla1869043d
Obesity and the Growth Hormone Axis
Henry, B. E., Jensen, E., List, E. O., & Berryman, D. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_12
Emiliano, A. B. (2018) · Springer eBooks · doi:10.1007/978-3-030-01039-3_16
Neuroendocrine Disorders in Women
Lovett, A. J., & Woodmansee, W. W. (2019) · Springer eBooks · doi:10.1007/978-3-030-04245-5_5
Katznelson, L. J. (2013) · doi:10.1002/9781118559406.ch21
Hyperglycémies iatrogènes en dehors du virus de l'immunodéficience humaine
Blicklé, J.-F., Tebacher, M., & Monassier, L. (2017) · Time to knit · doi:10.1016/s1155-1941(17)56362-3
Lima, T. H. I. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-04072019-152309
Erişkinde Hipopitüitarizmin Tanı ve Tedavisi
Şişman, P., & Gül, Ö. Ö. (2019) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.510272
Endocrine Care During Adolescence into Young Adulthood
Gleeson, H. K. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch19
Pseudo-Endocrine Disorders: Definitions, Examples, and Considerations
McDermott, M. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_1
Pseudo-Endocrine Disorders: My General Approach to Management of the Patient
McDermott, M. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_2
Rogue Practitioners and Practices
McDermott, M. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_3
Caputo, M., Mele, C., Ferrero, A., Leone, I., Marzullo, P., Prodam, F., & Aimaretti, G. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00794-0
Barrera, F. J., Raygoza-Cortez, K., García-Leal, M., Brito, J. P., Ospina, N. S., & Rodríguez‐Gutiérrez, R. (2021) · Endocrine · doi:10.1007/s12020-020-02592-y · Cited by 1
Transmisión Vertical del COVID-19: Revisión de 50 casos reportados
Pablo, T., & Barreto, N. (2021) · Ciencia y Salud · doi:10.22206/cysa.2021.v5i1.pp43-50
Saad, N., Mahajan, A. K., Chin, A., Stewart, D., & Kline, G. A. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01589-2
The influence of monoclonal antibodies for cancer treatment on the endocrine system
Dyrka, K., Witasik, D., Czarnywojtek, A., & Łącka, K. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.8889 · Cited by 1
Hypophysitis due to Immune Checkpoint Inhibitors
Azar, S. T. (2021) · Endocrinology and Disorders · doi:10.31579/2640-1045/055
Hiers, P. S., & Winter, W. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00003-2
Growth hormone assays and dynamic tests in the diagnosis of acromegaly and GH deficiency in adults
Markkanen, H. M. (2021) · Helda - University of Helsinki Institutional Repository · Cited by 1
Response to GH treatment after radiation therapy depends on location of irradiation
Rose, S. R., Carlsson, M. O., Grimberg, A., Aydin, F., Albanese, A., Acs, H.-K., & Camacho‐Hübner, C. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.9.12
Diagnosis and Treatment of Adult Growth Hormone Deficiency
Kim, J. H. (2021) · Korean Journal of Medicine · doi:10.3904/kjm.2021.96.5.400
Growth Hormone Deficiency in Childhood Germ Cell Tumor Survivors
Lone, D. W. (2021) · University of Minnesota Digital Conservancy (University of Minnesota)
Ultra-sensitive and multiplex detection of clinical biomarkers using a SPRi-based sensor
Zeidan, E. (2016) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Maurer, G. D., & Steinbach, J. P. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23824-6.00059-6
Karavitaki, N., Thompson, C. J., & Galloway, I. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198851899.003.0002
Jorge, A. A. L., Correa, F. A., & Scalco, R. C. (2022) · doi:10.1093/med/9780198870197.003.0181
Gleeson, H. K., & Wright, R. J. (2022) · doi:10.1093/med/9780198870197.003.0190
Drake, W. M., Keevil, B. G., & Trainer, P. J. (2022) · doi:10.1093/med/9780198870197.003.0006
(2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283567080
Physiopathology, Diagnosis, and Treatment of GH Deficiency
Tanrıverdi, F., & Keleştimur, F. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_2
Minuto, F. M., & Teti, C. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717967408.793467063
Somatropin therapy in italian adults with growth hormone deficiency
Pricci, F., Rotondi, D., Villa, M., Valerio, A., Agazio, E., & Roazzi, P. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00960-5
Tritos, N. A., & Klibanski, A. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch12
Craniopharyngioma and Posttreatment Pituitary Dysfunction in Brain Tumors
Felicetti, F. C., Prencipe, N., Brignardello, E., & Arvat, E. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_5-1
Szücs, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-62011-0_6
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_8
Moriyama, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820649-2.00053-x
Boguszewski, C. L. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726429846.793538661
Hipofunción hipofisaria y trastornos relacionados
Abreu-Lomba, A., González, K. D., Mera, M. A. E., Paredes, A. J., & Delgado-Truque, A. E. (2021) · Revista Colombiana Salud Libre · doi:10.18041/1900-7841/rcslibre.2020v15n1.7279
Kubo, H., Sawada, S., Satoh, M., Asai, Y., Kodama, S., Takahashi, K., Kaneko, K., Imai, J., Katagiri, H., Sato, T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1939345/v1
Yuen, K. C. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_19
Ovulation, Pregnancy, and Delivery in the Female Patient with Hypopituitarism
Dominguez, A. L., Danis, R. B., & Carmichael, J. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_13
Minimising Cardiometabolic Risk Factors in Patients with Hypopituitarism
Armeni, E., & Grossman, A. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_20 · Cited by 1
Bartke, A., & Brannan, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823679-6.00019-9
Growth Hormone Deficiency in Adults - Indications and Dosage
Correia, S., Silva, J., Tavares, P., Rocha, G., & Oliveira, M. (2023) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ar220024
Ren, Z., Peng, Y., Wang, Y., Shen, Y.-Y., Chen, J., Ren, W., & Liu, D. (2023) · Research Square · doi:10.21203/rs.3.rs-2636327/v1
Research Progress of Hypopituitarism
王, 姣. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.134981
Hypopituitarism in Adults: Rational Approaches to Diagnosis and Treatment
Almalki, M. (2023) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0043-1768587
ความชุกและปัจจัยที่สัมพันธ์กับภาวะพร่องฮอร์โมนต่อมหมวกไตแบบทุติยภูมิในอดีตนักมวยไทย
พิชญ์ชัยประเสริฐ, ส., & สนับบุญ, ธ. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.1638
การติดตามการทำงานของต่อมใต้สมองในผู้ป่วยที่หายจากการติดเชื้อไวรัสโคโรนา 2019
อู่สิริมณีชัย, ก. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.1016
Danda, V. S. R., Kyatham, V., Paidipally, S. R., Bhandiwad, C., & Palle, S. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_15_23
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch1
The Efficacy of Low-Dose Growth Hormone on Obesity: Meta-Analysis of Randomized Controlled TrialsPreprint
Sun, F., Jin, Y., Tian, L., Yu, X., Liang, S., Zhang, W., Zhao, G., & Gao, B. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4782548
van Nieuwpoort, I. C. (2024) · doi:10.5463/thesis.530
Bone Fragility Disorders in Childhood and Adolescence
Ward, L. M. (2024) · Endocrinology · doi:10.1007/978-3-030-18901-3_8-1 · Cited by 1
Hypophysenvorderlappen und Austestung der glandotropen Achsen
Schäffler, A., Bollheimer, C., Büttner, R., & Girlich, C. (2024) · Springer eBooks · doi:10.1007/978-3-662-68563-1_13
Maurer, G. D., & Steinbach, J. P. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21011-2.00060-0
Endocrine toxicity of cancer immunotherapy
Das, N., Tarenia, S. S., & Kalra, S. (2024) · International Journal of Molecular and Immuno Oncology · doi:10.25259/ijmio_19_2024
Nadarajah, N., Ssemmondo, E., Brooks, S., Akinyombo, R., Adeleke, K. A., Deshmukh, H., & Sathyapalan, T. (2024) · Intern J Endocrinol Metab · doi:10.5812/ijem-147825
“Conversely, prolonged GH treatment may be associated with fractures, adverse cardiovascular health, and cancer although the evidence from long-term clinical outcome studies is still deficient (23).”
BackgroundBone Fragility Disorders in Childhood and Adolescence
Ward, L. M. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_8
Effects of Growth Hormone on Osteoarthritis Development
Sun, L., Gang, X., Li, F. Y., Guo, W., Cui, M., & Wang, G. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2411-9344 · Cited by 1
Ilie, I. R. P., & Korbonits, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00108-4
Beck‐Peccoz, P., Höybye, C., Şimşek, S., Stalla, G. K., Murray, R. D., Esmael, A., Urosevic, D., Boldea, A., & Zabransky, M. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s471967
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.